MEXILETINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mexiletine, and what generic alternatives are available?
Mexiletine is a drug marketed by Ani Pharms, Annora Pharma, Crossmedika Sa, Ingenus Pharms Llc, Macleods Pharms Ltd, Quagen, Rising, Senores Pharms, Teva, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in MEXILETINE is mexiletine hydrochloride. There are five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the mexiletine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mexiletine
A generic version of MEXILETINE was approved as mexiletine hydrochloride by TEVA on May 16th, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEXILETINE?
- What are the global sales for MEXILETINE?
- What is Average Wholesale Price for MEXILETINE?
Summary for MEXILETINE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for MEXILETINE |
| DailyMed Link: | MEXILETINE at DailyMed |
US Patents and Regulatory Information for MEXILETINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 074711-003 | Feb 26, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 074711-001 | Feb 26, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 074865-003 | Apr 13, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 074865-001 | Apr 13, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
